Field & Main Bank’s Avanos Medical AVNS Stock Holding History

Field & Main Bank’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$1K	Hold	25	–	–	﹤0.01%	204
2015 Q1	$1K	Hold	25	–	–	﹤0.01%	201
2014 Q4	$1K	Buy	+25	New	+$982	﹤0.01%	201

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

RR Partners New York $929M AUM 110.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Field & Main Bank's AVNS Position: Q2 2015 in Review

Field & Main Bank held its Avanos Medical (AVNS) position steady in Q2 2015 at 25 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #204.

Field & Main Bank first reported a position in AVNS in Q4 2014 and has held it in 3 quarters since. 419 funds tracked by Wall St. Rank hold AVNS as of Q2 2015.

Field & Main Bank held 25 shares of Avanos Medical worth $1K as of Q2 2015.
Field & Main Bank left its Avanos Medical share count unchanged in Q2 2015.
Avanos Medical made up ﹤0.01% of Field & Main Bank's portfolio in Q2 2015, its #204 holding.
Field & Main Bank first reported a position in Avanos Medical in Q4 2014 and has held it in 3 quarters since.
419 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2015.

Based on Field & Main Bank's 13F filing for Q2 2015, filed 22 Jul 2015.